Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sartorius Stedim Biotech Share Issue/Capital Change 2021

Jan 4, 2021

1645_dva_2021-01-04_ede58e15-3ed4-4015-b3b9-d101600757c8.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Sartorius Stedim Biotech S.A. - 13781 Aubagne Cedex, France

Sartorius Stedim Biotech SA Z.I. Les Paluds Avenue de Jouques, CS 91051 13781 Aubagne Cedex, France

t:+33.(0)4.42.84.56.00 f:+33.(0)4.42.84.56 19 www.sartorius-stedim.com

S.A. au capital de 18,436,038 € RCS de Marseille B 314 093 352 SIRET 314 093 352 00073 – APE 6420Z TVA FR 49 314 093 352

DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

Article L 233-8-II of the Code of commerce and article 223-6 of the general regulations of the AMF

Designation of issuer

SARTORIUS STEDIM BIOTECH SA CS 91051 Z. I. Les Paluds Avenue de Jouques 13781 Aubagne Cedex

Date of information Total number of shares
making up the issued
capital
Total number of
theoretical voting rights
including treasury shares
Total number of net
voting rights
December 31, 2020 92,180,190 160,531,960 160,530,867